April 1, 2015

Biotechnology, Food & Drug Administration FDA News

Syndicate content

The National Law Review includes articles impacting the biotech and cleantech fields addressing: licensing and patent issues, intellectual property due diligence, litigation and tax. Content is also included addressing: greenhouse gas (GHG) regulation; mandated emissions reduction legislation; NEPA and CEQA claims, common law nuisance litigation; acquiring and selling emission offset and emission reduction credits and acid rain allowances under the United States Clean Air Act, SCAQMD RECLAIM and other air credit programs.

Date Title Organization
31
Mar
German Exemptions from Mandatory Rebates for Pharma Companies Are in Line with EU State Aid Rules Covington & Burling LLP
31
Mar
No Collateral Challenge Of Patent Application Revival Foley & Lardner LLP
30
Mar
FDA Issues Final Guidance on Reprocessing Medical Devices Barnes & Thornburg LLP
30
Mar
Real Parties in Interest Really Matter: GEA Process Engineering v. Steuben Foods McDermott Will & Emery
30
Mar
Perspectives on the President’s Precision Medicine Initiative Foley & Lardner LLP
28
Mar
Threshold Issues: IPR Not Derailed by Unidentified D/B/A Name or Prior ANDA Certification McDermott Will & Emery
28
Mar
TMI: When Does Fitness Data Become Too Much of a Good Thing? Greenberg Traurig, LLP
28
Mar
PhRMA's Objections to HSR Rule on Exclusive Licenses Face Skeptical Appellate Judges Schiff Hardin LLP
27
Mar
Strike Two – FDA Rejects Amgen’s Certification Petition for Biosimilar Applicants Sterne, Kessler, Goldstein & Fox P.L.L.C.
27
Mar
Fourth Circuit Sustains Securities Fraud Claim Against Drug Manufacturer Katten Muchin Rosenman LLP
26
Mar
European Food Safety Authority (EFSA) Grants Public Access to Data through Scientific “Data Warehouse” Covington & Burling LLP
26
Mar
FDA Issues Draft Guidance on Use of Electronic Informed Consent in Clinical Trials McDermott Will & Emery
26
Mar
Patent Term Adjustment In The Post-RCE Period -- Request for Continued Examination Foley & Lardner LLP
25
Mar
Failure to Warn About Dangers of Off-Label Use of Medical Device Preempted Under Federal Law Varnum LLP
25
Mar
Teva Pharmaceuticals: Is It Time to Rethink How You Will Argue Claim Construction? Dickinson Wright PLLC
25
Mar
Increased FTC Enforcement as FDA Deregulates Low-Rish Health IT Devices Morgan, Lewis & Bockius LLP
25
Mar
Northern District of California Judge Seeborg Opens the Door to Alternative Route to Challenge Patents on Biologics Schiff Hardin LLP
25
Mar
When on Antibiotics in Nursing Home or Hospital Watch for Diarrhea – It Could Be C-Diff Stark & Stark
24
Mar
While FDA’s Proposed e-Cigarette Rule is Pending, FTC Mulls Enforcement Action Morgan, Lewis & Bockius LLP
24
Mar
USPTO Myriad-Mayo Guidance Still Not At An Alpha Standard Schwegman, Lundberg & Woessner, P.A.

Advertisement

LATEST LEGAL NEWS & ANALYSIS

Covington & Burling LLP
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

TRENDING LEGAL ANALYSIS

Upcoming Legal Education Events